Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Chemotherapy use diverges from US breast cancer guidelines

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Chemotherapy use diverges from US breast cancer guidelines. Pharmacoecon. Outcomes News 402, 7 (2003). https://doi.org/10.1007/BF03275937

    Download citation

    Keywords

    • Breast Cancer
    • Health Outcome
    • Postmenopausal Woman
    • Adjuvant Chemotherapy
    • Health Economic